Results 31 to 40 of about 153,171 (297)

Blastic plasmacytoid dendritic cell neoplasm in children: diagnostic features and clinical implications

Haematologica, 2010
Background Blastic plasmacytoid dendritic cell neoplasm is a rare malignancy that typically follows a highly aggressive clinical course in adults, whereas experience in children with this disease is very limited.Design and Methods This retrospective ...
Armin G. Jegalian, Nataliya P. Buxbaum, Fabio Facchetti, Mark Raffeld, Stefania Pittaluga, Alan S. Wayne, Elaine S. Jaffe   +6 more
doaj   +1 more source

Blastic Plasmacytoid Dendritic cell neoplasm: Case report / Neoplasia de células Dendríticas Plasmocitóides Blásticas: Relato de caso [PDF]

, 2021
Blastic plasmacytoid dendritic cell neoplasm is a rare neoplasm of hematopoietic origin with poor clinical evolution. Here we report a case of a patient who presented with blastic plamacytoid dendritic cell neoplasm with cutaneous and nodal involvement ...
Sallum, Michel Hamui, de Souza, Helio Moraes, da Silva, Vanessa Afonso, de Vito, Fernanda Bernadelli   +3 more
core  

American Journal of Transplantation / Successful kidney transplantation in a patient with pre‐existing chronic myeloid leukemia treated with imatinib

, 2021
Active malignancy is an absolute contraindication to kidney transplantation. As for chronic myeloid leukemia (CML), a Philadelphia chromosome‐positive myeloproliferative neoplasm, the introduction of tyrosine kinase inhibitors has transformed CML from a ...
Webersinke, Gerald, Thiem, Ursula, Cejka, Daniel, Kranewitter, Wolfgang, Enkner, Wolfgang, Buxhofer-Ausch, Veronika   +5 more
core   +1 more source

Blastic plasmacytoid dendritic cell neoplasm [PDF]

Blastic plasmacytoid dendritic cell neoplasm is an uncommon, aggressive hematologic neoplasm carrying a poor prognosis with a median survival of one year, making early detection vital.
Olugbade, Idowu D., Dadras, Soheil S., Imahiyerobo-Ip, Joyce, Petty, Anna, Flynn, Elaine N.   +4 more
core   +1 more source

Clinical and Biological Features of Response in Resistant Neuroblastoma to 131I‐Metaiodobenzylguanidine Radiotherapy in the Anti‐GD2 Immunotherapy Era

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background 131I‐metaiodobenzylguanidine (131I‐MIBG) radiotherapy is a key treatment for relapsed and refractory (R/R) neuroblastoma (NB). Patients with R/R disease treated in the modern era are increasingly exposed to anti‐GD2 immunotherapy, which exerts selective pressure and may modify both tumor cell state and microenvironment.
Benjamin J. Lerman, Katherine K. Matthay, Fabienne Hollinger, Catriona Black, Ann A. Lazar, Miguel Pampaloni, Steven G. DuBois, Kieuhoa T. Vo   +7 more
wiley   +1 more source

Yield of Screening Colonoscopy in Renal Transplant Candidates

Canadian Journal of Gastroenterology and Hepatology, 2015
BACKGROUND: Cardiovascular disease is the most common cause of death among patients with end-stage renal disease undergoing maintenance dialysis. Renal transplantation offers a survival advantage to patients with end-stage renal disease; it is also ...
Turki AlAmeel, Bahaa Bseiso, Meteb M AlBugami, Sami AlMomen, Lee Stuart Roth   +4 more
doaj   +1 more source

Emapalumab for Immune Effector Cell‐Associated Hemophagocytic Lymphohistiocytosis‐Like Syndrome Following CD19‐Directed CAR‐T in Two Patients With B‐ALL: Clinical and Biomarker Correlates

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Immune effector cell‐associated hemophagocytic lymphohistiocytosis‐like syndrome (IEC‐HS) is a life‐threatening hyperinflammatory toxicity distinct from cytokine release syndrome (CRS) and neurotoxicity following chimeric antigen receptor T‐cell (CAR‐T) therapy. In a single‐institution retrospective cohort of pediatric and young adult patients
Thomas J. Galletta, Jeremy D. Rubinstein, Christopher E. Dandoy, Ruby Khoury, Angela Faulhaber, Christine L. Phillips, Christa Krupski   +6 more
wiley   +1 more source

Blastic Plasmacytoid Dendritic Cell Neoplasm: A Rapidly Progressive and Fatal Disease without Aggressive Intervention

Clinical Medicine Insights: Case Reports, 2013
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is an aggressive myeloid neoplasm derived from plasmacytoid monocytes. The most common presentation involves cutaneous manifestations, which are often accompanied by bone marrow involvement.
Lindsey Prochaska, Christopher Dakhil, Sharad Mathur   +2 more
doaj   +1 more source

Spindle Cell Neoplasm with Hyperbilirubinemia in a Renal Transplant Recipient: A Rare Case Report

, 2018
The risk of neoplasm increases after transplantation in patients with organ transplantation. Immunosuppressive treatments or oncogenic viruses are major risk factors.
Ö. İbrahim Karahan, ÇIRAK, Ayşenur, ÜNAL, Aydın, İsmail Koçyiğit, Kemal Deniz, Oktay Oymak, TOKGÖZ, Bülent, Ayşenur Çırak, Aydın Ünal, DENİZ, Kemal, Kocyigit, Ismail, OYMAK, Oktay, SIPAHIOGLU, Murat, Eray Eroğlu, Murat Sipahioğlu, Bülent Tokgöz, EROĞLU, Eray, KARAHAN, Ökkeş Ibrahim   +17 more
core   +1 more source

Predicting the course of hematopoietic neoplasm through oral bacterial examination

, 2022
Many medical institutions have recently conducted studies on the relationship between patients with hematopoietic neoplasms and oral cavity. Statistical analysis of the bacterial populations was performed in this study to identify how oral microflora and
ONO, Kaori, SHIRAKURA, Kyoko, OSAKABE, Luna, UTSUMI, Akemi, NAKAMAKI, Tsuyoshi, MYERS, Mie, SATO, Ayako, HIRONAKA, Shouji, YAMAGUCHI, Asako, HATTORI, Norimichi, MARUOKA, Yasubumi, SHIBATA, Yumi   +11 more
core   +1 more source